Maravai LifeSciences Forecast, price target & analysts
Maravai LifeSciences Target price 2025 - Analyst rating & recommendation
Maravai LifeSciences Classifications & Recommendation:
Maravai LifeSciences Price Target
| Target Price | $5.10 |
| Price | $2.57 |
| Potential |
98.44%
register free of charge
|
| Number of Estimates | 11 |
|
11 Analysts have issued a price target Maravai LifeSciences 2026 .
The average Maravai LifeSciences target price is $5.10.
This is
98.44%
register free of charge
$13.86
439.30%
register free of charge
$2.02
21.40%
register free of charge
|
|
| A rating was issued by 18 analysts: 11 Analysts recommend Maravai LifeSciences to buy, 7 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Maravai LifeSciences stock has an average upside potential 2026 of
98.44%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 259.19 | 198.61 |
| 10.30% | 23.37% | |
| EBITDA Margin | -26.27% | -14.19% |
| 236.12% | 45.98% |
14 Analysts have issued a sales forecast Maravai LifeSciences 2025 . The average Maravai LifeSciences sales estimate is
This results in the following potential growth metrics:
14 Analysts have issued an Maravai LifeSciences EBITDA forecast 2025. The average Maravai LifeSciences EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.05 | -0.29 |
| 16.67% | 72.38% | |
| P/E | negative | |
| EV/Sales | 3.58 |
14 Analysts have issued a Maravai LifeSciences forecast for earnings per share. The average Maravai LifeSciences EPS is
This results in the following potential growth metrics and future valuations:
Maravai LifeSciences...
Current Maravai LifeSciences Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| RBC Capital |
Locked
➜
Locked
|
Locked | Aug 12 2025 |
| Baird |
Locked
➜
Locked
|
Locked | May 13 2025 |
| Craig-Hallum |
Locked
➜
Locked
|
Locked | May 13 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Mar 25 2025 |
| UBS |
Locked
➜
Locked
|
Locked | Mar 21 2025 |
| B of A Securities |
Locked
➜
Locked
|
Locked | Mar 03 2025 |
| Baird |
Locked
➜
Locked
|
Locked | Feb 26 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
RBC Capital:
Locked
➜
Locked
|
Aug 12 2025 |
|
Locked
Baird:
Locked
➜
Locked
|
May 13 2025 |
|
Locked
Craig-Hallum:
Locked
➜
Locked
|
May 13 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Mar 25 2025 |
|
Locked
UBS:
Locked
➜
Locked
|
Mar 21 2025 |
|
Locked
B of A Securities:
Locked
➜
Locked
|
Mar 03 2025 |
|
Locked
Baird:
Locked
➜
Locked
|
Feb 26 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
